Cargando…
The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-prot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916420/ https://www.ncbi.nlm.nih.gov/pubmed/27328652 http://dx.doi.org/10.1038/srep28500 |
_version_ | 1782438826725081088 |
---|---|
author | Hemminki, Kari Försti, Asta Tuuminen, Raimo Hemminki, Otto Goldschmidt, Hartmut Sundquist, Kristina Sundquist, Jan Li, Xinjun |
author_facet | Hemminki, Kari Försti, Asta Tuuminen, Raimo Hemminki, Otto Goldschmidt, Hartmut Sundquist, Kristina Sundquist, Jan Li, Xinjun |
author_sort | Hemminki, Kari |
collection | PubMed |
description | Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high. |
format | Online Article Text |
id | pubmed-4916420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49164202016-06-27 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications Hemminki, Kari Försti, Asta Tuuminen, Raimo Hemminki, Otto Goldschmidt, Hartmut Sundquist, Kristina Sundquist, Jan Li, Xinjun Sci Rep Article Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high. Nature Publishing Group 2016-06-22 /pmc/articles/PMC4916420/ /pubmed/27328652 http://dx.doi.org/10.1038/srep28500 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Hemminki, Kari Försti, Asta Tuuminen, Raimo Hemminki, Otto Goldschmidt, Hartmut Sundquist, Kristina Sundquist, Jan Li, Xinjun The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
title | The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
title_full | The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
title_fullStr | The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
title_full_unstemmed | The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
title_short | The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications |
title_sort | incidence of senile cataract and glaucoma is increased in patients with plasma cell dyscrasias: etiologic implications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916420/ https://www.ncbi.nlm.nih.gov/pubmed/27328652 http://dx.doi.org/10.1038/srep28500 |
work_keys_str_mv | AT hemminkikari theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT forstiasta theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT tuuminenraimo theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT hemminkiotto theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT goldschmidthartmut theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT sundquistkristina theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT sundquistjan theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT lixinjun theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT hemminkikari incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT forstiasta incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT tuuminenraimo incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT hemminkiotto incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT goldschmidthartmut incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT sundquistkristina incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT sundquistjan incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications AT lixinjun incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications |